Loading...
Development of therapeutic anti-JAGGED1 antibodies for cancer therapy
The role of Notch signaling and its ligand JAGGED1 (JAG1) in tumor biology have been firmly established, making them appealing therapeutic targets for cancer treatment. Here we report the development and characterization of human/rat-specific JAG1-neutralizing monoclonal antibodies. Epitope mapping...
Saved in:
| Published in: | Mol Cancer Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7611158/ https://ncbi.nlm.nih.gov/pubmed/31395687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-18-1176 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|